|1.||Lycke, Nils: 1 article (06/2009)|
|2.||Tarkowski, Andrej: 1 article (06/2009)|
|3.||Hasselberg, Annemarie: 1 article (06/2009)|
|4.||Schön, Karin: 1 article (06/2009)|
06/01/2009 - "Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis."
06/01/2009 - "To determine whether a cholera toxin-derived, novel immunomodulating fusion protein, CTA1R7K-COL-DD, carrying the class II major histocompatibility complex H-2q-restricted type II collagen peptide aa 259-274, can induce therapeutic tolerance and prevent collagen-induced arthritis (CIA) when administered intranasally in DBA/1 mice, and to assess whether ADP-ribosylation at the mucosal membranes exerts a regulatory function such that the outcome of tolerance or immune enhancement can be controlled. "
|1.||Collagen Type II (Type II Collagen)
|3.||Adenosine Diphosphate (ADP)